LFCM
VINC

Long Focus Capital Management’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Long Focus Capital Management’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-53,075
Closed -$1.47M – 121
2022
Q3 		$1.47M Buy
+53,075
New +$1.53M 0.14% 64

Other funds holding VINC

SRC
Sage Rhino Capital Menlo Park, California $617M AUM 28.74% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Long Focus Capital Management's VINC Position: Q1 2024 in Review

Long Focus Capital Management sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q1 2024, closing a stake of 54,938 shares — an estimated $1.3M sold.

Long Focus Capital Management first reported a position in VINC in Q4 2021 and held it in 8 quarters. The position peaked at $1.72M in Q1 2022. 40 funds tracked by Wall St. Rank hold VINC as of Q1 2024.

  • Long Focus Capital Management reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Long Focus Capital Management sold 54,938 Vincerx Pharma, Inc. Common Stock shares in Q1 2024, an estimated $1.3M.
  • Long Focus Capital Management first reported a position in Vincerx Pharma, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Long Focus Capital Management's Vincerx Pharma, Inc. Common Stock position peaked at $1.72M in Q1 2022.
  • 40 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q1 2024.

Based on Long Focus Capital Management's 13F filing for Q1 2024, filed 14 May 2024.